Taro Igarashi
Download the ICS Branding Pack
Podium Short Oral Session 21 Overactive Bladder: Pharmacotherapy and Patient Phenotyping 216 Persistence of Vibegron treatment in elderly patients aged 80 years or over with overactive bladder: The impact of anticholinergic burden and polypharmacy
Podium Session 15 Best Basic Science 229 Effects of oral administration of non-selective Trk inhibitor on bladder overactivity in a rat model of prostatic inflammation
Open Discussion Session 35 On Demand Research Methods / Techniques 535 Effects of oral administration of non-selective Trk inhibitor on bladder function and prostatic inflammation in a mouse model of prostate-specific, conditional deletion of E-cadherin
Podium Short Oral Session 11 Therapeutic Mechanisms 161 Effects of oral administration of histamine-H1 receptor antagonist on bladder overactivity and prostatic inflammation in a rat model of non-bacterial prostatitis
Podium Session 19 Best Basic Science 257 Therapeutic effects of intravesical instillation of liposome-conjugated NGF antisense on NGF overexpression in the bladder and bladder overactivity in a rat model of prostatic inflammation
ICS Member
Scientific Committee Member